During the past decade, Almazov National Medical Research Centre conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 14 clinical trials were completed, i.e. on average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 12 clinical trials were completed. i.e. 48% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Almazov National Medical Research Centre" #1 sponsor was "Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health" with 11 trials, followed by "Geropharm" with 6 trials sponsored, "Kowa Research Institute, Inc." with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Almazov National Medical Research Centre" #1 collaborator was "Quintiles, Inc." with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "Les Laboratoires Servier (L.L.S), Russia" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator and "Albany Stratton VA Medical Center" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Almazov National Medical Research Centre" are "Acromegaly" (3 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Diseases" (3 trials), "Clamp Study" (3 trials) and "Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "Almazov National Medical Research Centre" in a lesser frequency.

Most popular intervention types in "Almazov National Medical Research Centre" are "Drug" (45 trials), "Other" (6 trials), "Procedure" (6 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dexamethasone" (3 trials), "K-877" (3 trials), "Bortezomib" (2 trials) and "Cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Almazov National Medical Research Centre" are 55 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 24 active trials in "Almazov National Medical Research Centre". 2 are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 28 completed trials in Almazov National Medical Research Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Almazov National Medical Research Centre, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".